5 Stocks Under $10 Set to Soar · By Roberto Pedone. Apr 30, 2015 9:34 AM EDT. View today's stock price, news and analysis for Bio-Path Holdings Inc. (BPTH). Barron's also provides information on historical stock ratings, target prices, The latest Bio-Path Holdings Inc USD0.001 share price. View recent trades and share price information for Bio-Path Holdings Inc USD0.001. Important Documents. There are no documents available for this stock. Recent dividends; Annual Bio-Path Holdings Inc (BPTH) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics. BPTH, Bio-Path Holdings Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. Technical Analysis for BPTH - Bio-Path Holdings Inc. Quote; Chart; Signals; Profile; Buy or Sell? News & Commentary; Indicators; Fundamentals
The all-time high Bio-Path Holdings stock closing price was 1148.00 on May 13, 2008. Aurinia Pharmaceuticals Inc (AUPH), Canada, $1.620B, 0.00. Ironwood
Bio-path Holdings, Inc. - BPTH - Stock Price Today - Zacks View Bio-Path Holdings, Inc. BPTH investment & stock information. Get the latest Bio-Path Holdings, Inc. BPTH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Bio-Path Holdings Inc., BPTH Quick Chart - (NAS) BPTH, Bio ... Bio-Path Holdings Reports Full Year 2019 Financial Results GlobeNewswire. 06:30 AM ET. Bio-Path Holdings, Inc. to Host Earnings Call ACCESSWIRE. Friday, February 28, 2020. 08:01 AM ET. Bio-Path Holdings to Announce Fourth Quarter and Full Year 2019 Financial Results on March 6, 2020 GlobeNewswire. More. Most recent headlines BPTH | Bio-Path Holdings Inc. Stock Price & News - WSJ View the latest Bio-Path Holdings Inc. (BPTH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Bio-Path Holdings Inc. (BPTH) Stock Message Board ...
View the latest BPTH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BIO-PATH HOLDINGS, INC..
Bio-Path Holdings Inc. [BPTH:US] | Bio-Path Holdings Inc ... Apr 05, 2020 · Bio-Path Holdings Inc is a United States based clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Bio-Path Holdings Inc BPTH - Quotes, Financials, News ... Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Bio-Path Holdings, Inc. (BPTH) Stock Historical Prices ... Discover historical prices for BPTH stock on Yahoo Finance. View daily, weekly or monthly format back to when Bio-Path Holdings, Inc. stock was issued.
BPTH: Bio-Path Holdings, Inc. - Zacks Investment Research
Bio-Path Holdings, Inc. - TheStreet Bio-Path Holdings To Announce Fourth Quarter And Full Year 2019 Financial Results On March 6, 2020. By GlobeNewswire. Feb 28, 2020 8:00 AM EST. INVESTING. 5 Stocks Under $10 Set to Soar. Bio-Path Holdings, Inc. (BPTH): Price and ... - Stock News Bio-Path Holdings, Inc. focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. The company was founded in 2007 and is based in Bellaire, Texas. BPTH Bio-Path Holdings, Inc. Stock Quote - FINVIZ.com
Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market Jan 18 2019 Bio-Path Holdings Announces 1-for-20 Reverse Stock Split Jan 18 2019 Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock Jan 17 2019 Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock
Bio-Path Holdings is a biotechnology company developing therapeutic products for IPO Status Public Stock Symbol NASDAQ:BPTH Company Type For Profit. View BPTH stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid Date, Type, Description. 03/20/2020 08:30 EDT, Misc, Bio-Path Holdings Inc Fourth Quarter Earnings Conference Call in 2019. 03/20/2020, Earnings, Bio- Path Bio-Path is a biotechnology company developing targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging Ratings Calendar · Stock Split Calendar · Ratings · Analyst Comments · Hot Analyst Comments · Analyst EPS Change · Analyst EPS View · Analyst PT Change
In depth view into Bio-Path Holdings Market Cap including historical data from 2008, charts, stats and industry comps. Stock Slips 6% MT Newswires 03/06 11:04 ET. Bio-Path slips 4% on FY results SA Breaking News 03/06 07:58 ET. Bio-Path Holdings Reports Full Year 2019 Financial Results Does Bio-Path Holdings, Inc.'s (NASDAQ:BPTH) CEO Bio-Path Holdings Inc (BPTH) News | Morningstar Bio-Path Holdings Announces Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia Provided by GlobeNewswire Nov 26, 2019 1:00 PM UTC GlobeNewswire Bio-Path Holdings (NASDAQ: BPTH): 2019 Earnings Snapshot Mar 06, 2020 · — Bio-Path Holdings Inc. (NASDAQ: BPTH) reported a loss of $3.24 share for the full year 2019, narrower than a loss of $14.38 per share in the previous year. — Research and development expenses remained flat from the last year at $4.6 million.